Miles Finn, Ph.D.

Miles Finn, Ph.D.

Robins Kaplan LLP

Contact  |  View Bio  |  RSS

Latest Publications

Share:

Helsinn Healthcare S.A. v. Hospira, Inc.

Case Name: Helsinn Healthcare S.A. v. Hospira, Inc., Civil No. 15-2077 (MLC), 2016 U.S. Dist. LEXIS 45826 (D.N.J. Apr. 5, 2016) (Cooper, J.) - Drug Product and Patents-in-Suit: Aloxi® (palonosetron); U.S. Patents Nos....more

8/16/2016 - ANDA FDA Federal Rule 12(b)(6) Generic Drugs Hatch-Waxman Hospira Patent Infringement Patent Litigation Patent-in-Suit Patents Personal Jurisdiction Pharmaceutical Industry Pharmaceutical Patents Prescription Drugs

Otsuka Phama. Co., Ltd. v. Zydus Pharms. USA, Inc., et al.

Case Name: Otsuka Phama. Co., Ltd. v. Zydus Pharms. USA, Inc., et al., Civil Action Nos. 14-3168 (JBS/KMW), 2016 U.S. Dist. LEXIS 48689 (D.N.J. Apr. 12, 2016) (Simandle, C.J.) - Drug Product and Patent(s)-in-Suit:...more

8/15/2016 - Generic Drugs Hatch-Waxman Otsuka Pharmaceutical Patent Infringement Patent Litigation Patent-in-Suit Patents Pharmaceutical Industry Pharmaceutical Patents Prescription Drugs

Allergan, Inc. v. Teva Pharmaceuticals USA, Inc.

Case Name: Allergan, Inc. v. Teva Pharmaceuticals USA, Inc., Civ. No. 15-cv-1455 (WCB), 2016 U.S. Dist. LEXIS 51851 (E.D. Tex. Apr. 19, 2016) (Bryson, J.) - Drug Product and Patent(s)-in-Suit: Restasis® (cyclosporine...more

8/12/2016 - Allergan Inc Generic Drugs Hatch-Waxman Jurisdiction Mylan Pharmaceuticals Patent Infringement Patent Litigation Patent-in-Suit Patents Pharmaceutical Industry Pharmaceutical Patents Prescription Drugs Teva Pharmaceuticals

Pfizer Inc. v. Sandoz Inc

Case Name: Pfizer Inc. v. Sandoz Inc., C.A. No. 13-1110-GMS, 2016 U.S. Dist. LEXIS 52762 (D. Del. Apr. 20, 2016) (Sleet, J.) - Drug Product and Patent(s)-in-Suit: Toviaz® (fesoterodine fumarate); U.S. Patents Nos....more

8/11/2016 - ANDA Generic Drugs Hatch-Waxman Patent Infringement Patent Litigation Patent-in-Suit Patents Pfizer Pharmaceutical Industry Pharmaceutical Patents Prescription Drugs Sandoz

Bayer Pharma AG v. Watson Labs., Inc

Case Name: Bayer Pharma AG v. Watson Labs., Inc., Civ. No. 12-cv-517 (GMS), 2016 U.S. Dist. LEXIS 55752 (D. Del. Apr. 27, 2016) (Sleet, J.) - Drug Product and Patent(s)-in-Suit: Staxyn® (vardenafil hydrochloride...more

8/10/2016 - ANDA Bayer Generic Drugs Hatch-Waxman Patent Infringement Patent Litigation Patent-in-Suit Patents Pharmaceutical Industry Pharmaceutical Patents Prescription Drugs Watson Pharmaceuticals

Endo Pharm. Inc. v. Amneal Pharms. LLC

Case Name: Endo Pharm. Inc. v. Amneal Pharms. LLC, Civil Nos. 12 Civ. 8115 (TPG),12 Civ. 8060 (TPG),12 Civ. 8317 (TPG),12 Civ. 8985 (TPG),13 Civ. 435 (TPG),13 Civ. 436 (TPG),13 Civ. 3288 (TPG),13 Civ. 4343 (TPG),13 Civ. 8597...more

8/8/2016 - ANDA Endo Pharmaceuticals Generic Drugs Hatch-Waxman Patent Infringement Patent Litigation Patent-in-Suit Patents Pharmaceutical Industry Pharmaceutical Patents Prescription Drugs

Bayer Pharma AG v. Watson Labs., Inc.

Case Name: Bayer Pharma AG v. Watson Labs., Inc., Civ. No. 12-cv-517 (GMS), 2016 U.S. Dist. LEXIS 57888 (D. Del. May 2, 2016) (Sleet, J.) - Drug Product and U.S. Patent(s)-in-Suit: Staxyn® and Levitra® (vardenafil...more

8/5/2016 - Bayer Generic Drugs Hatch-Waxman Patent Infringement Patent Litigation Patent-in-Suit Patents Pharmaceutical Industry Pharmaceutical Patents Prescription Drugs Watson Pharmaceuticals

Genzyme Corp. v. Dr. Reddy’s Labs., Ltd.

Case Name: Genzyme Corp. v. Dr. Reddy’s Labs., Ltd., C.A. No. 13-1506-(GMS), 2016 U.S. Dist. LEXIS 62056 (D. Del. May 11, 2016) (Sleet, J.) - Drug Product and Patent(s)-in-Suit: Mozobil® (plerixafor solution); U.S. Pat....more

8/4/2016 - ANDA FDA Generic Drugs Genzyme Hatch-Waxman Patent Infringement Patent Litigation Patents Pharmaceutical Industry Pharmaceutical Patents Prescription Drugs Prior Art

Takeda Pharms. U.S.A., Inc. v. West-ward Pharm. Corp.

Case Name: Takeda Pharms. U.S.A., Inc. v. West-ward Pharm. Corp., Civ. No. 14-1268-SLR, 2016 U.S. Dist. LEXIS 65317 (D. Del. May 18, 2016) (Robinson, J.) - Drug Product and Patent(s)-in-Suit: Colcrys® (colchicine); U.S....more

8/3/2016 - FDA Generic Drugs Hatch-Waxman Induced Infringement Patent Infringement Patent Litigation Patent-in-Suit Patents Pharmaceutical Industry Pharmaceutical Patents Prescription Drugs Takeda Pharmaceuticals

Ferring B.V. v. Actavis, Inc.

Case Name: Ferring B.V. v. Actavis, Inc., Civil No. 15-4222 (SRC)(CLW), 2016 U.S. Dist. LEXIS 69328 (D.N.J. May 26, 2016) (Chesler, J.) - Drug Product and Patents-in-Suit: Lysteda® (tranexamic acid); U.S. Patent No....more

8/2/2016 - Actavis Inc. ANDA FDA Federal Rule 12(b)(1) Federal Rule 12(b)(6) Generic Drugs Hatch-Waxman Patent Applications Patent Infringement Patent Litigation Patents Pharmaceutical Industry Pharmaceutical Patents Prescription Drugs Watson Pharmaceuticals

Reckitt Benckiser Pharms, Inc. v. Watson Labs., Inc.

Case Name: Reckitt Benckiser Pharms, Inc. v. Watson Labs., Inc., Civil No. 13-1674-RGA, 2016 U.S. Dist. LEXIS 72391 (D. Del. June 3, 2016) (Andrews, J.) - Drug Product and Patent(s)-in-Suit: Suboxone® (buprenorphine HCl...more

8/1/2016 - ANDA Generic Drugs Hatch-Waxman Opioid Patent Infringement Patent Litigation Patents Pharmaceutical Industry Pharmaceutical Patents Prescription Drugs Watson Pharmaceuticals

In Re Bendamustine Consolidated Cases

Case Name: In Re Bendamustine Consolidated Cases, No. 13-2046-GMS, 2016 U.S. Dist. LEXIS 75624 (D. Del. June 10, 2016) (Sleet, J.) - Drug Product and Patent(s)-in-Suit: Treanda® (bendamustine HCl); U.S. Patents Nos....more

7/29/2016 - Generic Drugs Hatch-Waxman Patent Infringement Patent Litigation Patent-in-Suit Patents Pharmaceutical Industry Pharmaceutical Patents Prescription Drugs

Merck & Cie v. Watson Labs., Inc.

Case Name: Merck & Cie v. Watson Labs., Inc., 2015-2063, -2064, 2016 U.S. App. LEXIS 8782 (Fed. Cir. May 13, 2016) (Circuit Judges Dyk, Mayer, and Hughes presiding; Opinion by Mayer, J.) (Appeal from D. Del., Andrews, J.)...more

7/28/2016 - Generic Drugs Hatch-Waxman Merck Patent Infringement Patent Litigation Patents Pharmaceutical Industry Pharmaceutical Patents Prescription Drugs Watson Pharmaceuticals

Intendis GMBH et al. v. Glenmark Pharms. Inc., USA

Case Name: Intendis GMBH et al. v. Glenmark Pharms. Inc., USA, 822 F.3d 1355 (Fed. Cir. May 16, 2016) (Circuit Judges Prost, Moore, and Taranto presiding; Opinion by Moore, J.) (Appeal from D. Del., Robinson, J.) - Drug...more

7/27/2016 - ANDA Bayer FDA Generic Drugs Hatch-Waxman Patent Infringement Patent Litigation Patent-in-Suit Patents Pharmaceutical Industry Pharmaceutical Patents Prescription Drugs Prior Art

Spectrum Pharms., Inc. v. Burwell

Case Name: Spectrum Pharms., Inc. v. Burwell, No. 15-5166, 2016 U.S. App. LEXIS 10095 (D.C. Cir. June 3, 2016) (Circuit Judges Griffith, Cavanaugh, and Wilkins presiding; Opinion by Griffith) (Appeal from D.D.C., Lamberth,...more

7/26/2016 - ANDA FDA Generic Drugs Hatch-Waxman Orphan Drugs Patent Infringement Patent Litigation Patents Pharmaceutical Industry Pharmaceutical Patents Prescription Drugs Sandoz Spectrum

Teva receives license to three patents covering oxycodone dosage forms

Purdue Pharma L.P. et al. v. Teva Pharmaceuticals USA, Inc.; Purdue Pharma L.P. et al. v. Teva Pharmaceuticals USA, Inc. Case Number: 1:13-cv-04606-SHS; 1:14-cv-02357-SHS - Teva settled with plaintiffs in two...more

2/16/2015 - OxyContin Patents Pharmaceutical Industry Pharmaceutical Patents Teva Pharmaceuticals

Judge Hellerstein refused to stay case pending resolution of other cases involving the patents in suit

Intellectual Ventures I LLC, et al. v. Citigroup, Inc., et al. Case Number: 1:14-cv-04638 - Citigroup moved to stay this case, which involved five patents related to cyber security and the protection of customer...more

2/13/2015 - Citigroup Patent Litigation Patent-in-Suit Patents

Amount of fees and non-taxable costs in exceptional case to be sealed

TNS Media Research, LLC (d/b/a) Kantar Media Audiences and Cavendish Square Holding, B.V. Case Number: 1:11-cv-04039-SAS - Following Judge Scheindlin’s finding this case exceptional, the parties stipulated to an...more

2/12/2015 - Attorney's Fees Exceptional Case Patent Litigation Patents

Findthebest.com awarded approximately $302K in attorneys’ and costs under 35 USC § 285

Lumen View Technology LLC v. Findthebest.com Case Number: 1:13-cv-03599-DLC Having denied Lumen View's motion for reconsideration of a finding that this case is exceptional...more

2/11/2015 - Attorney's Fees Exceptional Case Patent Litigation Patents

Claims to a method of making a baseball highlight video not infringed

Baseball Quick, LLC v. MLB Advanced Media L.P. Case Number: 1:11-cv-01735-KBF - Judge Forrest granted summary judgment of non-infringement of claims for producing a highlight video of a baseball game....more

2/10/2015 - Baseball Patent Infringement Patent Litigation Patents Sports Summary Judgment Video Recordings

The BPCIA’s framework for patent dispute resolution counsels against the exercise of declaratory judgment jurisdiction

Celltrion Healthcare Co., Ltd. et al. v. Kennedy Trust for Rheumatology Research; Hospira, Inc. v. Janssen Biotech, Inc. et al. Case Number: 1:14-cv-02256; 1:14-cv-07049 On the same day, Judge Crotty granted two...more

2/9/2015 - Biosimilars BPCIA Declaratory Judgments Dispute Resolution FDA Patent Litigation Patents

Production of prosecuting attorney’s memorandum about prior art waives privilege

Regeneron Pharmaceuticals, Inc. v. Merus B.V. Case Number: 1:14-cv-01650-KBF Judge Forrest, having determined that Regeneron’s production of a memorandum discussing prior art was a waiver of attorney-client...more

2/6/2015 - Attorney-Client Privilege Patent Litigation Patents Pharmaceutical Industry Pharmaceutical Patents Prior Art

For product claims, the “use” of an accused product that operates outside the U.S. still fails within the reach of Section 271(a)...

Blue Spike, LLC v. Soundmouse Ltd - Case Number: 1:14-cv-02243 - Judge McMahon, addressing the territorial reach of “use” within the United States under Section 271, granted in part and denied in part Defendant...more

2/5/2015 - Extraterritoriality Rules Patent Infringement Patent Litigation Patents

1+ year delay post-answer in counterclaiming for invalidity and non-infringement is acceptable under Rule 15

Endo Pharmaceuticals, Inc. and Grüenthal GmbH v. Teva Pharmaceuticals USA, Inc. and Barr Laboratories, Inc. Case Number: 1:12-cv-08060-TPG-GWG - Teva delayed more than one year between answering a complaint...more

2/4/2015 - Endo Pharmaceuticals Patent Infringement Patent Litigation Patents Pharmaceutical Industry Pharmaceutical Patents Teva Pharmaceuticals

Contrary claim construction at USPT no reason to reconsider court’s construction

Enzo Biochem, Inc. et al. v. Molecular Probes, Inc. Case Number: (1:03-cv-03816-RJS) - Judge Sullivan denied Enzo’s request to reconsider the court’s claim construction of U.S. Patent No. 5,449,767 (“Modified...more

2/3/2015 - Claim Construction Patent Litigation Patents USPTO

112 Results
|
View per page
Page: of 5

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:

Sign up to create your digest using LinkedIn*

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.

Already signed up? Log in here

*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.
×